As medical researchers and clinicians, we are concerned about the proposed reductions in funding for the U.S. National ...

Our purpose was to evaluate the performance of the Biograph Vision Quadra PET/CT system. This new system is based on the Biograph Vision 600, using the same silicon photomultiplier–based detectors ...

Journal of Nuclear Medicine June 2025, jnumed.125.269655; DOI: https://doi.org/10.2967/jnumed.125.269655 ...

Journal of Nuclear Medicine February 2025, jnumed.124.268967; DOI: https://doi.org/10.2967/jnumed.124.268967 Cancer therapy has advanced with molecularly targeted ...

Journal of Nuclear Medicine April 2025, jnumed.124.269361; DOI: https://doi.org/10.2967/jnumed.124.269361 ...

The field of nuclear medicine is going through a renaissance with significant investment by a biotechnology and pharmaceutical industry finally recognizing the benefits of the theranostic paradigm.

Single-domain antibody (sdAb) is among the most promising vectors for developing molecular imaging tracers. Several sdAb tracers targeting human epidermal growth factor receptor 2 or programmed death ...

Journal of Nuclear Medicine May 2025, jnumed.124.268938; DOI: https://doi.org/10.2967/jnumed.124.268938 ...

EDA-FN is abundant in BC, with high EDA-FN expression associated with poor overall survival (15). Hormone receptor- and human epidermal growth factor receptor 2–negative BCs, collectively known as ...

Journal of Nuclear Medicine April 2025, jnumed.124.269203; DOI: https://doi.org/10.2967/jnumed.124.269203 ...

Prostate-specific membrane antigen (PSMA) PET is a well-established imaging tool for the evaluation of primary and recurrent prostate cancer (PCa). 177 Lu PSMA-targeted radiopharmaceutical therapy ...

TO THE EDITOR: Radiopharmaceuticals for PET imaging are regulated as drugs by the U.S. Food and Drug Administration (FDA) through several offices within the Center for Drug Evaluation and Research, ...